RecruitingNot ApplicableNCT05296941

Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD)

Screening for Oral Cancer for Early Detection of Premalignant Disorders

Sponsor

Dalarna County Council, Sweden

Enrollment

200 participants

Start Date

Aug 1, 2023

Study Type

INTERVENTIONAL

Conditions

Mouth Neoplasms

Summary

Cancer is a complex disease; its different causes and types have a strong impact on patient treatment and prognosis. To improve understanding of the disease, its causes and progression, the investigators will develop a simple, cost-effective system for continuous control of mucosal lesions with non-invasive brush biopsy that can be managed in primary dental care, as an alternative to tissue biopsy in order to reduce the number of oral cavity cancers.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a screening tool to detect premalignant (pre-cancer) disorders in the mouth, such as leukoplakia (white patches) and erythroplakia (red patches), at an early stage before they potentially develop into oral cancer. **You may be eligible if...** - You are 18 years or older - You have been clinically diagnosed with a premalignant oral condition such as leukoplakia, erythroplakia, or proliferative verrucous leukoplakia **You may NOT be eligible if...** - You cannot read or understand information written in Swedish - You are currently undergoing chemotherapy or radiation therapy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.